FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899042314> ?p ?o ?g. }

• W2899042314 endingPage "6986" @default.
• W2899042314 startingPage "6961" @default.
• W2899042314 abstract "Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer Tugba Yildiz,1 Renpeng Gu,2 Stefan Zauscher,2 Tania Betancourt1,3 1Materials Science, Engineering, and Commercialization Program, Texas State University, San Marcos, TX, 2Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 3Department of Chemistry and Biochemistry, Texas State University, San Marcos, TX, USA Introduction: Despite significant progress in the field of oncology, cancer remains one of the leading causes of death. Chemotherapy is one of the most common treatment options for cancer patients but is well known to result in off-target toxicity. Theranostic nanomedicines that integrate diagnostic and therapeutic functions within an all-in-one platform can increase tumor selectivity for more effective chemotherapy and aid in diagnosis and monitoring of therapeutic responses. Material and methods: In this work, theranostic nanoparticles were synthesized with commonly used biocompatible and biodegradable polymers and used as cancer contrast and therapeutic agents for optical imaging and treatment of breast cancer. These core–shell nanoparticles were prepared by nanoprecipitation of blends of the biodegradable and biocompatible amphiphilic copolymers poly(lactic-co-glycolic acid)-b-poly-l-lysine and poly(lactic acid)-b-poly(ethylene glycol). Poly-l-lysine in the first copolymer was covalently decorated with near-infrared fluorescent Alexa Fluor 750 molecules. Results: The spherical nanoparticles had an average size of 60–80 nm. The chemotherapeutic drug doxorubicin was encapsulated in the core of nanoparticles at a loading of 3% (w:w) and controllably released over a period of 30 days. A 33-fold increase in near-infrared fluorescence, mediated by protease-mediated cleavage of the Alexa Fluor 750-labeled poly-l-lysine on the surface of the nanoparticles, was observed upon interaction with the model protease trypsin. The cytocompatibility of drug-free nanoparticles and growth inhibition of drug-loaded nanoparticles on MDA-MB-231 breast cancer cells were investigated with a luminescence cell-viability assay. Drug-free nanoparticles were found to cause minimal toxicity, even at high concentrations (0.2–2,000 µg/mL), while doxorubicin-loaded nanoparticles significantly reduced cell viability at drug concentrations >10 µM. Finally, the interaction of the nanoparticles with breast cancer cells was studied utilizing fluorescence microscopy, demonstrating the potential of the nanoparticles to act as near-infrared fluorescence optical imaging agents and drug-delivery carriers. Conclusion: Doxorubicin-loaded, enzymatically activatable nanoparticles of less than 100 nm were prepared successfully by nanoprecipitation of copolymer blends. These nanoparticles were found to be suitable as controlled drug delivery systems and contrast agents for imaging of cancer cells. Keywords: nanomedicine, theranostics, drug delivery, fluorescence imaging, enzymatic activation, nanoprecipitation, block copolymers, PLGA, PLA, PEG, poly-l-lysine, nanoparticles" @default.
• W2899042314 created "2018-11-09" @default.
• W2899042314 creator A5009063866 @default.
• W2899042314 creator A5040489938 @default.
• W2899042314 creator A5056730987 @default.
• W2899042314 creator A5059795073 @default.
• W2899042314 date "2018-10-01" @default.
• W2899042314 modified "2023-10-05" @default.
• W2899042314 title "Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer" @default.
• W2899042314 cites W1560056785 @default.
• W2899042314 cites W1572736799 @default.
• W2899042314 cites W1821945515 @default.
• W2899042314 cites W1905198696 @default.
• W2899042314 cites W1965730097 @default.
• W2899042314 cites W1976751505 @default.
• W2899042314 cites W1977871291 @default.
• W2899042314 cites W1979917813 @default.
• W2899042314 cites W1980779214 @default.
• W2899042314 cites W1983540559 @default.
• W2899042314 cites W1989545341 @default.
• W2899042314 cites W1994930469 @default.
• W2899042314 cites W1995024863 @default.
• W2899042314 cites W1997518603 @default.
• W2899042314 cites W1998588165 @default.
• W2899042314 cites W2000352722 @default.
• W2899042314 cites W2000381333 @default.
• W2899042314 cites W2008171455 @default.
• W2899042314 cites W2012192443 @default.
• W2899042314 cites W2014716705 @default.
• W2899042314 cites W2022532937 @default.
• W2899042314 cites W2023203327 @default.
• W2899042314 cites W2023887149 @default.
• W2899042314 cites W2027278669 @default.
• W2899042314 cites W2029753193 @default.
• W2899042314 cites W2030878444 @default.
• W2899042314 cites W2032870077 @default.
• W2899042314 cites W2035661290 @default.
• W2899042314 cites W2039568250 @default.
• W2899042314 cites W2040049368 @default.
• W2899042314 cites W2045681528 @default.
• W2899042314 cites W2046314109 @default.
• W2899042314 cites W2047993500 @default.
• W2899042314 cites W2049815086 @default.
• W2899042314 cites W2052566050 @default.
• W2899042314 cites W2054745605 @default.
• W2899042314 cites W2058680827 @default.
• W2899042314 cites W2062264676 @default.
• W2899042314 cites W2062545425 @default.
• W2899042314 cites W2069049795 @default.
• W2899042314 cites W2069502900 @default.
• W2899042314 cites W2070838947 @default.
• W2899042314 cites W2074544404 @default.
• W2899042314 cites W2076589334 @default.
• W2899042314 cites W2079141522 @default.
• W2899042314 cites W2094005944 @default.
• W2899042314 cites W2098781727 @default.
• W2899042314 cites W2109056070 @default.
• W2899042314 cites W2110104127 @default.
• W2899042314 cites W2110279822 @default.
• W2899042314 cites W2111488320 @default.
• W2899042314 cites W2112031278 @default.
• W2899042314 cites W2118844383 @default.
• W2899042314 cites W2126410573 @default.
• W2899042314 cites W2127714324 @default.
• W2899042314 cites W2135244514 @default.
• W2899042314 cites W2140608909 @default.
• W2899042314 cites W2140613480 @default.
• W2899042314 cites W2148438596 @default.
• W2899042314 cites W2153409108 @default.
• W2899042314 cites W2158787062 @default.
• W2899042314 cites W2158925802 @default.
• W2899042314 cites W2168337851 @default.
• W2899042314 cites W2187895018 @default.
• W2899042314 cites W2240104466 @default.
• W2899042314 cites W2253332708 @default.
• W2899042314 cites W2264583710 @default.
• W2899042314 cites W2316581203 @default.
• W2899042314 cites W2345099171 @default.
• W2899042314 cites W2512578283 @default.
• W2899042314 cites W2560781439 @default.
• W2899042314 cites W2563665409 @default.
• W2899042314 cites W2581967109 @default.
• W2899042314 cites W2592741852 @default.
• W2899042314 cites W2736301719 @default.
• W2899042314 cites W2747376235 @default.
• W2899042314 cites W2749263049 @default.
• W2899042314 cites W2755706916 @default.
• W2899042314 cites W2766551075 @default.
• W2899042314 cites W2794954838 @default.
• W2899042314 cites W4299874396 @default.
• W2899042314 cites W2107165601 @default.
• W2899042314 doi "https://doi.org/10.2147/ijn.s174068" @default.
• W2899042314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6217908" @default.
• W2899042314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30464453" @default.
• W2899042314 hasPublicationYear "2018" @default.
• W2899042314 type Work @default.
• W2899042314 sameAs 2899042314 @default.
• W2899042314 citedByCount "44" @default.

• next